O'Shaughnessy Asset Management’s Revolution Medicines RVMD Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86M	Buy	15,274 +6,380	+72%	+$932K	0.01%	753
2026 Q1	$865K	Buy	8,894 +2,362	+36%	+$239K	﹤0.01%	1253
2025 Q4	$520K	Buy	+6,532	New	+$428K	﹤0.01%	1483
2025 Q1	–	Sell	-4,788	Closed	-$209K	–	2382
2024 Q4	$209K	Sell	4,788 -200	-4%	-$10.1K	﹤0.01%	1728
2024 Q3	$246K	Buy	+4,988	New	+$217K	﹤0.01%	1569
2021 Q3	–	Sell	-2,010	Closed	-$64K	–	2841
2021 Q2	$64K	Hold	2,010	–	–	﹤0.01%	1486
2021 Q1	$92K	Hold	2,010	–	–	﹤0.01%	1228
2020 Q4	$80K	Buy	+2,010	New	+$79.5K	﹤0.01%	1132

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

O'Shaughnessy Asset Management's RVMD Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Revolution Medicines (RVMD) stake by 72% in Q2 2026, buying an estimated $932K and bringing the position to 15,274 shares worth $2.86M. The position accounts for 0.01% of the portfolio, ranked #753.

O'Shaughnessy Asset Management first reported a position in RVMD in Q4 2020 and has held it in 8 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

O'Shaughnessy Asset Management held 15,274 shares of Revolution Medicines worth $2.86M as of Q2 2026.
O'Shaughnessy Asset Management bought 6,380 Revolution Medicines shares in Q2 2026, an estimated $932K.
Revolution Medicines made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #753 holding.
O'Shaughnessy Asset Management first reported a position in Revolution Medicines in Q4 2020 and has held it in 8 quarters since.
694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.